New-onset psoriasis associated with etanercept therapy

Journal of Dermatology

Volumn 37, Issue 4, 2010, Pages 378-380

  Chen, Lu An ^a   Su, Lin Hui ^a   Chang, Ying Jui ^a   Hsu, Yu Ling ^a   Tsai, Tsung Hua ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ACANTHOSIS; ADULT; ARTHRITIS; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; LOW DRUG DOSE; MALE; MORNING STIFFNESS; NEUTROPHIL CHEMOTAXIS; PAPULE; PARAKERATOSIS; PSORIASIS; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN ULCER;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; ISOXAZOLES; MALE; METHOTREXATE; PREDNISOLONE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950209252     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00789.x     Document Type: Letter

References (10)

1. Lee HH, Song IH, Friedrich M et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007 156 : 486 491.
2. Gottlieb AB, Matheson RT, Lowe N et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol 2003 139 : 1627 1632 discussion 32.
3. Dereure O, Guillot B, Jorgensen C et al. Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases. Br J Dermatol 2004 151 : 506 507.
4. Sfikakis PP, Iliopoulos A, Elezoglou A et al. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 2005 52 : 2513 2518.
5. Michaelsson G, Kajermo U, Michaelsson A et al. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct? Br J Dermatol 2005 153 : 1243 1244.
6. Kary S, Worm M, Audring H et al. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 2006 65 : 405 407.
7. de Gannes GC, Ghoreishi M, Pope J et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007 143 : 223 231.
8. Wendling D, Balblanc JC, Briancon D et al. Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy. Joint Bone Spine 2008 75 : 315 318.
9. Collamer AN, Guerrero KT, Henning JS et al. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008 59 : 996 1001.
10. Wollina U, Hansel G, Koch A et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008 9 : 1 14.